Frequency of p53 codon 72 genotypes in human papillomavirus associated squamous intraepithelial lesions and cervical cancer

Anticancer Research

Volumn 19, Issue 3 B, 1999, Pages 2377-2379

  Szarka, Krisztina ^a   Veress, György ^a   Kónya, József ^a   Gergely, Lajos ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Cervical cancer; Human papillomavirus; p53 alleles; Risk factor

Indexed keywords

PROTEIN P53;

ARTICLE; CODON; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CANCER; WART VIRUS;

ARGININE; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; CODON; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENES, P53; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HUNGARY; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0032780552     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. zur Hausen H, de Villiers EM: Human papillomaviruses. Annu Rev Microbiol 48: 427-447, 1994.
2. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Mathlasewski G and Banks L: Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229-234, 1998.
3. Manos MM, Ting Y, Wright DK, Lewis AJ and Broker TR: Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7: 209-214, 1989.
4. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM and Wheeler CM: Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphism, nucleotide sequence, and phylogenetic algorithms. JID 170: 1077-1085, 1994.
5. Evander M, Bodin E, Bjersing L, Rylander E and Wadell G: Oligonucleotide primers for DNA amplification of the early regions 1, 6 and 7 from human papillomavirus types 6, 11, 16, 18, 31, and 33. Arch Virol 16: 221-233, 1991.
6. Stöppler MC, Ching K, Stöppler H, Clancy K, Schlegel R and Icenogle J: Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol 70: 6987-6993, 1996.
7. Zehbe I, Wilander E, Delius H and Tommasino M: Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58: 829-833, 1998.
8. Mannion C, Park WS, Man YG, Zhuang Z, Albores-Saavedra, J. and Tavassoli FA: Endocrine tumours of the cervix: morphologic assessment, expression of human papillomavirus, and evaluation for loss of heterozygosity on 1p,3p, 11q, and 17p. Cancer 83: 1391-1400, 1998.
9. Rosenthal AN, Ryan A, Rajai MA-J, Storey A, Harwood C and Jacobs JJ: p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet 552: 871-875, 1998.
10. Minaguchi T, Kanamori Y, Matsushima M, Yoshikawa H, Taketani Y and Nakamura Y: No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res 55: 4585-4586, 1998.
11. Lanham S, Campbell I, Watt P and Gornall R: p53 polymorphism and risk of cervical cancer. Lancet 352: 1631, 1998.